AFF3 is a Prognostic Biomarker Correlated with Immune Infiltrates in Triple-Negative Breast Cancer
Background: Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer that cannot be treated with targeted therapies such as endocrine therapy or anti-HER-2 (anti-human epidermal growth factor receptor 2) therapy. In the growth of tumors, AFF3 (AF4/FMR2 family member 3) plays a cri...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2023-08-01
|
| Series: | Clinical and Experimental Obstetrics & Gynecology |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/CEOG/50/8/10.31083/j.ceog5008165 |